If effective, Johnson & Johnson's one-dose vaccine could quickly help large swaths of the United States develop immunity to COVID-19. That would be a game changer.
Government advisers determined that the benefits of the Pfizer-BioNTech vaccine is safe and effective, clearing the way for final FDA approval of the shot this week.